| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.0066 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |